Redhawk Wealth Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,682
Closed -$109K 430
2026
Q1
$109K Buy
+10,682
New +$115K 0.01% 378
2023
Q1
Sell
-7,743
Closed -$893K 200
2022
Q4
$893K Buy
+7,743
New +$902K 0.35% 86
2021
Q3
Sell
-1,026
Closed -$290K 260
2021
Q2
$290K Buy
+1,026
New +$278K 0.06% 191
2018
Q4
Sell
-2,537
Closed -$562K 128
2018
Q3
$562K Buy
+2,537
New +$514K 0.31% 61

Other funds holding MED

Redhawk Wealth Advisors's MED Position: Q2 2026 in Review

Redhawk Wealth Advisors sold out of Medifast (MED) in Q2 2026, closing a stake of 10,682 shares — an estimated $109K sold.

Redhawk Wealth Advisors first reported a position in MED in Q3 2018 and held it in 4 quarters. The position peaked at $893K in Q4 2022. 9 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Redhawk Wealth Advisors reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 10,682 Medifast shares in Q2 2026, an estimated $109K.
  • Redhawk Wealth Advisors first reported a position in Medifast in Q3 2018 and held it in 4 quarters.
  • Redhawk Wealth Advisors's Medifast position peaked at $893K in Q4 2022.
  • 9 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.